<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2014//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_140101.dtd">
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30584645</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>08</Month>
            <Day>12</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-2584</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>51</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Mar</Month>
                    </PubDate>
                </JournalIssue>
                <Title>International urology and nephrology</Title>
                <ISOAbbreviation>Int Urol Nephrol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Relationship between plasma levels of sclerostin, calcium-phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients.</ArticleTitle>
            <Pagination>
                <MedlinePgn>519-526</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11255-018-2050-3</ELocationID>
            <Abstract>
                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Data concerning the relation between increased levels of circulating sclerostin (a physiological inhibitor of bone formation) and bone turnover in patients with chronic renal failure (CRF) are limited. Therefore, the aim of this study was to evaluate associations between plasma sclerostin levels and calcium-phosphate disturbances, markers of bone turnover as well as inflammation in haemodialysis (HD) patients.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">In plasma samples obtained in 150 stable HD patients (92 men) aged 40-70 years, levels of sclerostin, fibroblast growth factor (cFGF23), osteocalcin, the N-terminal propeptide of type I procollagen, C-terminal telopeptide of the alpha chain of type I collagen (Î²-CTx), and inflammatory markers (IL-6 and TNF-Î±) in addition to routine parameters (calcium, phosphorus, parathyroid hormone-iPTH, 25-OH-D, alkaline phosphatase) were measured.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Plasma sclerostin concentrations were significantly higher in HD men than women (2.61 vs. 1.88Â ng/mL, pâ&lt;â0.01). Patients with sclerostin levels above median were characterized by lower iPTH and IL-6, but higher cFGF23 and TNF-Î± (significantly only in men) concentrations. Plasma sclerostin concentration positively correlated with serum 25-OH-D (Ïâ=â0.204), phosphorus (Ïâ=â0.1482), and TNF-Î± (Ïâ=â0.183) and inversely with iPTH (Ïâ=â-â0.255), alkaline phosphatase (Ïâ=â-â0.203), IL-6 (Ïâ=-â0.201), and Î²-CTx (Ïâ=â-â0.099) levels. In multivariate regression analysis, variability of sclerostin levels was explained by sex and 25-OH-D and phosphorus levels.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Increased circulating sclerostin levels seem to reflect slower bone turnover in HD patients. Low levels of sclerostin are associated with vitamin D deficiency and good phosphates alignment.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pietrzyk</LastName>
                    <ForeName>Barbara</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pathophysiology Unit, Department of Pathophysiology, Medical University of Silesia, Katowice, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wyskida</LastName>
                    <ForeName>Katarzyna</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Promotion and Obesity Management Unit, Department of Pathophysiology, Medical University of Silesia, Katowice, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ficek</LastName>
                    <ForeName>Joanna</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pathophysiology Unit, Department of Pathophysiology, Medical University of Silesia, Katowice, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kolonko</LastName>
                    <ForeName>Aureliusz</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, Katowice, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ficek</LastName>
                    <ForeName>RafaÅ</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, Katowice, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>WiÄcek</LastName>
                    <ForeName>Andrzej</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, Katowice, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Olszanecka-Glinianowicz</LastName>
                    <ForeName>Magdalena</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Promotion and Obesity Management Unit, Department of Pathophysiology, Medical University of Silesia, Katowice, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chudek</LastName>
                    <ForeName>Jerzy</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pathophysiology Unit, Department of Pathophysiology, Medical University of Silesia, Katowice, Poland. chj@poczta.fm.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine and Oncological Chemotherapy, School of Medicine in Katowice, Medical University of Silesia in Katowice, 40-752, Katowice, Poland. chj@poczta.fm.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>KNW-1-004/N/7/0</GrantID>
                    <Agency>Medical University of Silesia in Katowice</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>24</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Int Urol Nephrol</MedlineTA>
            <NlmUniqueID>0262521</NlmUniqueID>
            <ISSNLinking>0301-1623</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D019485">Bone Morphogenetic Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D024042">Collagen Type I</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C508600">IL6 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010281">Parathyroid Hormone</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010455">Peptides</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010710">Phosphates</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C422903">SOST protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C052929">collagen type I trimeric cross-linked peptide</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>104982-03-8</RegistryNumber>
                <NameOfSubstance UI="D015675">Osteocalcin</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>1406-16-2</RegistryNumber>
                <NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>27YLU75U4W</RegistryNumber>
                <NameOfSubstance UI="D010758">Phosphorus</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>62031-54-3</RegistryNumber>
                <NameOfSubstance UI="D005346">Fibroblast Growth Factors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>7Q7P4S7RRE</RegistryNumber>
                <NameOfSubstance UI="C416507">fibroblast growth factor 23</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>A288AR3C9H</RegistryNumber>
                <NameOfSubstance UI="C104450">25-hydroxyvitamin D</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.1.3.1</RegistryNumber>
                <NameOfSubstance UI="D000469">Alkaline Phosphatase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>SY7Q814VUP</RegistryNumber>
                <NameOfSubstance UI="D002118">Calcium</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000469" MajorTopicYN="N">Alkaline Phosphatase</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019485" MajorTopicYN="N">Bone Morphogenetic Proteins</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016723" MajorTopicYN="Y">Bone Remodeling</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012080" MajorTopicYN="N">Chronic Kidney Disease-Mineral and Bone Disorder</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024042" MajorTopicYN="N">Collagen Type I</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005346" MajorTopicYN="N">Fibroblast Growth Factors</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005819" MajorTopicYN="N">Genetic Markers</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015675" MajorTopicYN="N">Osteocalcin</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010281" MajorTopicYN="N">Parathyroid Hormone</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010710" MajorTopicYN="N">Phosphates</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010758" MajorTopicYN="N">Phosphorus</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Calciumâphosphate disturbances</Keyword>
            <Keyword MajorTopicYN="N">Chronic kidney disease-mineral and bone disorder (CKD-MBD)</Keyword>
            <Keyword MajorTopicYN="N">Haemodialysis patients</Keyword>
            <Keyword MajorTopicYN="N">Renal osteodystrophy (ROD)</Keyword>
            <Keyword MajorTopicYN="N">Sclerostin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30584645</ArticleId>
            <ArticleId IdType="doi">10.1007/s11255-018-2050-3</ArticleId>
            <ArticleId IdType="pii">10.1007/s11255-018-2050-3</ArticleId>
            <ArticleId IdType="pmc">PMC6424932</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>EMBO J. 2003 Dec 1;22(23):6267-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14633986</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bone. 2005 Aug;37(2):148-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15946907</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Endocrinology. 2005 Nov;146(11):4577-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16081646</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Bone Miner Metab. 2006;24(2):164-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16502126</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Biochem. 2007 May 1;101(1):80-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17212358</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Physiol. 2008 Mar;214(3):740-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17786964</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2008 Feb;118(2):421-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18246192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Calcif Tissue Int. 2010 Aug;87(2):99-107</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20473488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Bone Miner Res. 2011 Feb;26(2):331-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20734454</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin J Am Soc Nephrol. 2011 Apr;6(4):877-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21164019</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2011 Jun;79(12):1370-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21389978</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2012 Jan;27(1):226-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21613383</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Bone Miner Res. 2011 Dec;26(12):2812-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21812027</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Calcif Tissue Int. 2012 Jun;90(6):473-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22527202</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Endocrinol Metab. 2014 Aug;99(8):2897-907</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24606091</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Endocrinol Metab. 2014 Nov;99(11):4315-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25093620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Blood Press Res. 2014;39(4):230-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25118597</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Osteoporos Int. 2014 Oct;25(10):2359-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25182228</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Osteoporos Int. 2015 Mar;26(3):1017-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25366373</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephron Clin Pract. 2014;128(1-2):127-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25377055</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2015 May;87(5):1039-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25493951</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Endocrinol. 2015 Sep 15;413:157-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26112182</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Scand J Immunol. 2016 Jan;83(1):58-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26448366</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Clin Endocrinol Diabetes. 2017 Oct;125(9):634-637</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26824280</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biomark Med. 2016 Jul;10(7):689-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27347702</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Blood Press Res. 2016;41(5):519-526</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27529627</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nutr Metab Cardiovasc Dis. 2017 Mar;27(3):260-266</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28017524</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Urol Nephrol. 2017 Apr;49(4):717-725</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28044237</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2017 May 11;12(5):e0176411</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28493902</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Steroid Biochem Mol Biol. 2018 Jun;180:15-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29331722</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>